The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU ® (trastuzumab deruxtecan) in combination with pertuzumab for the first-line ...
Findings challenge prevailing ignition–sustainment assumptions, reframing plasma instability as a systems-level ...
EMA validates Enhertu plus pertuzumab type II variation application in EU as first-line treatment of patients with HER2 positive metastatic breast cancer: Tokyo Tuesday, January 2 ...
TMC the metals company offers a deep-sea mining opportunity with a resource base covering nearly 100 years of critical metals ...
The texture is lightweight but deeply hydrating: an emerald-toned, fluid serum that absorbs almost instantly and leaves my ...
The Secretary found that semiconductors are essential to each of the 16 critical infrastructure sectors identified by ...
Gedatolisib's phase 3 breast cancer success supports a Buy ahead of potential 2026 FDA approval. Click here to read more.
In 2025, persistent macro uncertainty and rapidly shifting crypto narratives turned asset selection into a defining pillar of ...
Unlike conventional trading platforms, Navia Backup operates independently of Navia's primary trading infrastructure, ...
The new pressed powder pretty much contains the same ingredients as the fan-favorite loose powder — minus vitamin E, talc, and fragrance. They’re similar products, both intended to create a blurring ...
From screwworm threats near the southern border to shifting global poultry trade, producers are heading into 2026 with ...
On September 17, 2025, the SEC issued an order approving new “generic” listing standards that are music to the ears of commodity-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback